Opdivo24ml (Nivolumab Vials) 240mg/24ml

Nivolumab 240mg/24ml solution in vials is an immunotherapy medication used to treat certain cancers. It belongs to the class of PD-1 inhibitors, helping the immune system recognize and attack cancer cells. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance for use.

Strength

240mg/24ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Bristol- Myers Squibb

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nivolumab 240mg/24ml is primarily used to treat melanoma, lung cancer, kidney cancer, and other malignancies. It works by blocking the PD-1 protein, which helps the immune system identify and destroy cancer cells more effectively. This medication is often prescribed when other treatments have not been successful or as part of a combination therapy.

Side Effects

Patients may experience general effects such as fatigue, nausea, or skin reactions while using Nivolumab. Some individuals report flu-like symptoms or changes in appetite. These effects vary by person and are typically monitored by a healthcare professional during treatment.

Precautions & Warnings

Keep Nivolumab 240mg/24ml vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Handle with care to avoid contamination, and dispose of any unused medication as directed by a healthcare provider or local regulations.

Avoid Interactions

Nivolumab may interact with other immunotherapies or medications that affect the immune system, such as corticosteroids. Alcohol and certain supplements may also influence its effects. Always inform your healthcare provider about all medications and supplements you are taking before starting Nivolumab.

Frequently Asked Questions

Nivolumab 240mg/24ml is used to treat certain types of cancer by helping the immune system target cancer cells.

Store Nivolumab between 2-8°C and protect from light; do not freeze or shake the vial.

Consult your healthcare provider before taking other medications, as some may interact with Nivolumab.

Common effects may include fatigue, nausea, or skin reactions, which should be reported to a healthcare professional.

Nivolumab is a treatment option for certain cancers but is not a guaranteed cure; effectiveness varies by individual.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.